Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
BIIB

Biogen Inc

Stocks

3 Undervalued Stocks to Buy This Week

March 29, 2022 by Money Morning Staff Reports

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The stock market has taken some hits so far in 2022, but this move lower has opened up opportunities to buy up high-quality stocks at discount prices.And there are 3 undervalued stocks to buy this week that can outperform over the years to come.

Read more...

Options

The Two Best Stocks to Trade Right Now

January 7, 2022 by Shah Gilani

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Shah Gilani has the tickers for the two best stocks to trade right now..

Read more...

Stocks

5 Stocks to Sell in May 2021

May 5, 2021 by Money Morning Staff Reports

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

"Sell in May and go away" might be popular advice.

But it could cost you if you sell your entire portfolio.

But leaving these toxic stocks in won't be any better.

To make the most of the trend, here are the stocks to sell now...

Technology

The Answer to Big Pharma's Biggest Problem Could Double Your Money in Just Three Years

November 19, 2019 by Michael A. Robinson

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

You could forgive drug and biotech executives for having a bad case of target fixation.

After all, they do work in a field that is filled with time-consuming and expensive headaches.

Consider that the Biotechnology Innovation Organization (BIO), the world's largest biotech trade organization, looked at 7,400 drug programs by 1,103 companies. They were investigating drug-approval rates.

The news was not good -just 9.6% of drugs scientists discover ever get approved for sale. That's a one-in-ten shot.

With such daunting data, it's no wonder that, even in a field already worth $1.2 trillion in global sales, industry leaders are on the lookout for ways to lower the cost of discovery and shorten time to market.

And with that goal in mind, I've uncovered a high-octane, large-cap firm that has become an essential ingredient in the drug sector's success.

It's a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure.

And it's been doubling its earnings, on average, every 18 months...

Dow Jones

The Dow Jones Industrial Average Is Flat as the Trade War Dashes Earnings Expectations

October 22, 2019 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones Industrial Average will not see much growth today, as a number of big Dow components are feeling the impacts of the U.S.-China trade war.

Many blame the trade war between the United States and China on lower sales, higher shipping costs.

I'll address these stories further in this column...

Stocks

Three Biotech Stocks Poised to Break Out

August 22, 2019 by Money Morning Staff Reports

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

With recession indicators flashing, investors are flocking to 10-year bonds that have the annual upside of just 1.5%.

But there are still market-beating stocks out there – in fact, one of our picks expects 103% growth.

And that brings us to the biotech industry.

There are some big biotech stocks to own right now that could deliver double, even triple-digit upside in less than 12 months.

Read more here...

Wall Street

What Wall Street Gets Wrong About the Inverted Yield Curve

March 28, 2019 by Keith Fitz-Gerald

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Things that'll be "different this time" usually aren't, especially when it comes to hot stoves, hot steering wheels, and hot bond markets. Touch 'em and you'll get burned, or so goes the thinking.

Every once in a while, though, the situation plays out.

Take the inverted yield curve that caused last Friday's vicious selloff and made countless headlines around the world when it happen for the first time since 2007.

Contrary to what Wall Street and legions of economists want you to believe, it may NOT be the harbinger of doom that it's been for the past 50 years.

Here's my case (and what to buy if you're interested in big profits)…

Read More…

Dow Jones

What Could Send the Dow Jones Today on a 100-Point Slide

March 21, 2019 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones today might see a triple-digit slip as investors digest the latest weekly jobless report and ongoing concerns about global economic growth.

Markets also did not rally after the Federal Reserve announced it would remain dovish on interest rates through the end of 2019.

Read more...

Biotechnology

The 2 Best Biotech Stocks to Buy Now

March 14, 2019 by Money Morning News Team

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Biotech companies are known for their potential to break out when a new drug comes to market, and today we're giving you two of the best biotech stocks to buy now.

Buying the top biotech stocks offers the sort of upside that's so hard to find right now.

And we've screened the biotech industry in the VQScore system to uncover our top biotech stocks to buy right now...

stocks

2 More Biotech Stocks Are Flashing Buy Signals Today

February 22, 2019 by Jamie Dlugosch

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

At the end of 2018, the Federal Reserve told the market the water was warm, come in for a swim.

The market was happy to oblige. In fact, the S&P 500 has rebounded almost 11% to start 2019, nearly erasing all of the losses from December.

It's as if the sell-off never happened.

Right now, the market is an absolute dream for stock pickers. And biotech stocks in particular are looking incredibly lucrative...

First
  • 1
  • 2
NextLast
Latest News

September 22, 2023 • By Shah Gilani

earnings
Why the Fed's "Higher for Longer" Message on Interest Rates is Bogus

September 22, 2023 • By Tom Gentile

This is the Top 'Worst-in-Breed' Stock Heading into October

September 22, 2023 • By Garrett Baldwin

Will The Fed Bankrupt the Tooth Fairy?
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information